Barinthus Biotherapeutics plc. Quarterly Current Ratio in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Barinthus Biotherapeutics plc. quarterly Current Ratio history and growth rate from Q3 2021 to Q3 2024.
  • Barinthus Biotherapeutics plc. Current Ratio for the quarter ending September 30, 2024 was 1.01K %, a 27.9% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 1.01K -391 -27.9% Sep 30, 2024
Q2 2024 1.01K -610 -37.6% Jun 30, 2024
Q1 2024 1.17K -534 -31.4% Mar 31, 2024
Q4 2023 1.29K -327 -20.2% Dec 31, 2023
Q3 2023 1.4K -275 -16.4% Sep 30, 2023
Q2 2023 1.62K -391 -19.4% Jun 30, 2023
Q1 2023 1.7K -554 -24.5% Mar 31, 2023
Q4 2022 1.62K -953 -37.1% Dec 31, 2022
Q3 2022 1.68K -612 -26.7% Sep 30, 2022
Q2 2022 2.01K Jun 30, 2022
Q1 2022 2.26K Mar 31, 2022
Q4 2021 2.57K Dec 31, 2021
Q3 2021 2.29K Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.